MCK - McKesson Corporation
On CNBC's “Mad Money Lightning Round,” Jim Cramer said McKesson Corporation (NYSE:MCK) is a “winner” and it will go much higher. “It is exactly what you buy in this environment," he added.
Sax Wealth Advisors LLC purchased a new position in McKesson Corporation (NYSE: MCK) during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 691 shares of the company's stock, valued at approximately $590,000. A number of other institutional investors and
First Citizens Bank and Trust Co. grew its stake in McKesson Corporation (NYSE: MCK) by 95.9% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,830 shares of the company's stock after purchasing an additional 2,365 shares during the period. First
McKesson (MCK) reached $976.57 at the closing of the latest trading day, reflecting a +1.53% change compared to its last close.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Terra Nova Asset Management LLC increased its stake in shares of McKesson Corporation (NYSE: MCK) by 31.6% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,995 shares of the company's stock after buying an additional 720 shares during the quarter.
Vertrix Wealth Management LLC lessened its position in McKesson Corporation (NYSE: MCK) by 10.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 5,179 shares of the company's stock after selling 593 shares during the quarter. McKesson makes up about
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Sapient Capital LLC acquired a new stake in shares of McKesson Corporation (NYSE: MCK) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,076 shares of the company's stock, valued at approximately $919,000. Other institutional investors and
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here is how McKesson (MCK) and Avantor, Inc. (AVTR) have performed compared to their sector so far this year.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
In the closing of the recent trading day, McKesson (MCK) stood at $910.33, denoting a -1.23% move from the preceding trading day.
McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Option Care Health Inc. (NASDAQ:OPCH) agreed Tuesday to be taken private by Clayton Dubilier & Rice and McKesson Corp. (NYSE:MCK) for $32.05 a share in cash. The deal gives the home-infusion provider a total enterprise value of about $5.8 billion.
Private equity firm CD&R and McKesson Corporation (NYSE:MCK) on Tuesday agreed to acquire Option Care Health Inc. (NASDAQ:OPCH) for $32.05 per share.
Mckesson Corp (NYSE:MCK), the US healthcare services and drug distribution company, and Clayton Dubilier & Rice (CD&R), the private investment firm, have agreed to acquire Option Care Health (NASDAQ:OPCH) for approximately $5.8 billion. The buyers will pay $32.05 a share for Option Care Health, the largest independent provider of home and alternate-site infusion services in the US, representing a 37% premium to Monday's closing price.
Under the agreement, CD&R will hold a majority interest of about 51% in Option Care Health, while McKesson will hold about 49%.
What happened McKesson Corporation (NYSE: MCK) said on October 6, 2026, it signed a definitive agreement with Clayton, Dubilier Rice, LLC and Option Care Health, Inc. CD R will hold about 51% of Option Care Health and McKesson will invest about $1.4 billion for a minority interest of about 49%. The deal values Option Care